Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patient safety organizations

This article was originally published in The Gray Sheet

Executive Summary

HHS on Nov. 21 finalized a 1regulation establishing patient safety organizations - third-party groups certified by the government to accept patient safety event information from health care practitioners on a confidential basis. Required by the Patient Safety and Quality Improvement Act of 2005, PSOs are intended to give practitioners a way to report events without fear that the information will be used against them in lawsuits or professional sanctions. They do not negate FDA adverse event reporting requirements for devices and drugs (2"The Gray Sheet" Feb. 18, 2008, p. 7)

You may also be interested in...



Proposed Reg Offers Doctors More Discreet Way To Report Adverse Events

A proposed federal rule could increase the number of adverse event reports available for public analysis

Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch

The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.

Sandoz Pledges Price Stability Amid Coronavirus

Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.

UsernamePublicRestriction

Register

MT026828

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel